Christina Rolling
Dr. med.
Christina Charlotte Rolling
  • Functional senior physician
  • Medical Specialist in Internal Medicine
  • Hämostaseologie
Working area

Location

O24
Languages
German (Mother tongue)
Spanish
English

Areas of expertise

Memberships

Publications

Zurück
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
Vor

Long-term cardiotoxicity in germ cell cancer survivors after platinum-based chemotherapy: cardiac MR shows impaired systolic function and tissue alterations
Beitzen-Heineke A, Rolling C, Seidel C, Erley J, Molwitz I, Muellerleile K, Saering D, Senftinger J, Börschel N, Engel N, Bokemeyer C, Adam G, Tahir E, Chen H
EUR RADIOL. 2024;34(6):4102-4112.

Effect of factor XI inhibition on tumor cell-induced coagulation activation
Mäder J, Rolling C, Voigtländer M, Schulenkorf A, Lehr C, Regenhardt J, Bokemeyer C, Beckmann L, Langer F
J THROMB HAEMOST. 2024;22(1):199-212.

Circulating Tumor Cells and Thromboembolic Events in Patients with Glioblastoma
Rolling C, Mohme M, Bokemeyer C, Westphal M, Riethdorf S, Lamszus K, Pantel K, Klingler F, Langer F
HAMOSTASEOLOGIE. 2024 [Epub ahead of print].

Platelet LGALS3BP as a Mediator of Myeloid Inflammation in Systemic Lupus Erythematosus
El Bannoudi H, Cornwell M, Luttrell-Williams E, Engel A, Rolling C, Barrett T, Izmirly P, Belmont H, Ruggles K, Clancy R, Buyon J, Berger J
ARTHRITIS RHEUMATOL. 2023;75(5):711-722.

Regulation of coagulation activation in newly diagnosed AML by the heme enzyme myeloperoxidase
Langer F, Quick H, Beitzen-Heineke A, Janjetovic S, Mäder J, Lehr C, Bokemeyer C, Kuta P, Renné T, Fiedler W, Beckmann L, Klingler F, Rolling C
THROMB RES. 2023;229:155-163.

Platelet-monocyte aggregates: molecular mediators of thromboinflammation
Rolling C, Barrett T, Berger J
FRONT CARDIOVASC MED. 2023;10:960398.

Absence of Malaria-Associated Coagulopathy in Asymptomatic Plasmodium falciparum Infection: Results From a Cross-sectional Study in the Ashanti Region, Ghana
Rolling C, Phillips R, Abass K, Ken Adu Poku J, Osei-Mireku S, Osei-Wusu B, Thompson W, Vinnemeier C, Huebl L, Langer F, Francke P, Kuta P, Konrath S, Renné T, Tannich E, Rolling T, Heinemann M
OPEN FORUM INFECT DI. 2023;10(3):ofad074.

P2Y12 Inhibition Suppresses Proinflammatory Platelet-Monocyte Interactions
Rolling C, Sowa M, Wang T, Cornwell M, Myndzar K, Schwartz T, El Bannoudi H, Buyon J, Barrett T, Berger J
THROMB HAEMOSTASIS. 2023;123(2):231-244.

Purpura Fulminans Triggered by the Formation of Anti-Endothelial Autoantibodies in a Patient with Chronic Lymphocytic Leukemia
Beckmann L, Lennartz M, Beitzen-Heineke A, Voigtländer M, Rolling C, Holstein K, Bokemeyer C, Amirkhosravi A, Langer F
Ann Hematol Oncol. 2022;9(1):.

Inhibition of protein disulfide isomerase with PACMA-31 regulates monocyte tissue factor through transcriptional and posttranscriptional mechanisms
Beckmann L, Mäder J, Voigtlaender M, Klingler F, Schulenkorf A, Lehr C, Regenhardt J, Bokemeyer C, Ruf W, Rolling C, Langer F
THROMB RES. 2022;220:48-59.

Evaluation of different diagnostic tools for detection of acquired von Willebrand syndrome in patients with polycythemia vera or essential thrombocythemia
Janjetovic S, Rolling C, Budde U, Schneppenhem S, Schafhausen P, Peters M, Bokemeyer C, Holstein K, Langer F
THROMB RES. 2022;218:35-43.

PO-31: The small-molecule FXIa inhibitor, BMS-26208, prevents tumor cell-induced coagulation activation predominantly in tumor entities with lower tissue factor (TF) expression
Mäder J, Voigtländer M, Rolling C, Quick H, Schulenkorf A, Lehr C, Bokemeyer C, Beckmann L, Langer F
THROMB RES. 2022;213(Suppl 2):.

Safety and preliminary activity results of the GATTO study, a phase Ib study combining the anti-TA-MUC1 antibody gatipotuzumab with the anti-EGFR tomuzotuximab in patients with refractory solid tumors
Ochsenreither S, Fiedler W, Conte G, Macchini M, Matos I, Habel B, Ahrens-Fath I, Raspagliesi F, Lorusso D, Keilholz U, Rolling C, Kebenko M, Klinghammer K, Saavedra O, Baumeister H, Zurlo A, Garralda E
ESMO OPEN. 2022;7(2):.

Platelets amplify endotheliopathy in COVID-19
Barrett T, Cornwell M, Myndzar K, Rolling C, Xia Y, Drenkova K, Biebuyck A, Fields A, Tawil M, Luttrell-Williams E, Yuriditsky E, Smith G, Cotzia P, Neal M, Kornblith L, Pittaluga S, Rapkiewicz A, Burgess H, Mohr I, Stapleford K, Voora D, Ruggles K, Hochman J, Berger J
SCI ADV. 2021;7(37):eabh2434.

Bacitracin and Rutin Regulate Tissue Factor Production in Inflammatory Monocytes and Acute Myeloid Leukemia Blasts
Beckmann L, Rolling C, Voigtländer M, Mäder J, Klingler F, Schulenkorf A, Lehr C, Bokemeyer C, Ruf W, Langer F
CANCERS. 2021;13(16):3941.

Monocyte activation and acquired autoimmune protein S deficiency promote disseminated intravascular coagulation in a patient with primary antiphospholipid syndrome
Beckmann L, Voigtländer M, Holstein K, Lennartz M, Schneider S, Haddad M, Renné T, Bokemeyer C, Rolling C, Langer F
RES PRACT THROMB HAE. 2021;5(5):.

Myeloperoxidase has no effect on the low procoagulant activity of silica-free DNA
Beckmann L, Voigtländer M, Rolling C, Schulenkorf A, Bokemeyer C, Langer F
THROMB RES. 2021;2021(203):36-45.

Platelet Conditioned Media Induces an Anti-inflammatory Macrophage Phenotype through EP4
Heffron S, Weinstock A, Scolaro B, Chen S, Sansbury B, Marecki G, Rolling C, El Bannoudi H, Barrett T, Canary J, Spite M, Berger J, Fisher E
J THROMB HAEMOST. 2021;19(2):562-573.

Prevalence of definite antiphospholipid syndrome in carriers of the JAK2V617F mutation
Janjetovic S, Beckmann L, Holstein K, Rolling C, Thiele B, Schafhausen P, Schön G, Bokemeyer C, Langer F, Voigtlaender M
THROMB RES. 2021;198:55-61.

High prevalence of asymptomatic malaria infections in adults, Ashanti Region, Ghana, 2018
Heinemann M, Phillips R, Vinnemeier C, Rolling C, Tannich E, Rolling T
MALARIA J. 2020;19(1):366.

Comparison of acetylsalicylic acid and clopidogrel non-responsiveness assessed by light transmittance aggregometry and PFA-100® in patients undergoing neuroendovascular procedures
Rolling C, Tomada J, Frölich A, Holst B, Holstein K, Voigtländer M, Janjetovic S, Haddad M, Renné T, Fiehler J, Bokemeyer C, Rolling T, Langer F
CLIN CHEM LAB MED. 2020;59(2):383-392.

Effect of myeloperoxidase on the anticoagulant activity of low-molecular-weight heparin and rivaroxaban in an in-vitro tumor model
Voigtländer M, Beckmann L, Schulenkorf A, Sievers B, Rolling C, Bokemeyer C, Langer F
J THROMB HAEMOST. 2020;18(12):3267-3279.

Apixaban for the Treatment of Chronic Disseminated Intravascular Coagulation: A Report of Two Cases
Janjetovic S, Holstein K, Dicke C, Bokemeyer C, Langer F
HAMOSTASEOLOGIE. 2019;39(3):294-297.

Myeloperoxidase Is a Negative Regulator of Phospholipid-Dependent Coagulation
Beckmann L, Dicke C, Spath B, Lehr C, Sievers B, Klinke A, Baldus S, Rudolph V, Langer F
THROMB HAEMOSTASIS. 2017;117(12):2300-2311.

Distinct mechanisms account for acquired von Willebrand syndrome in plasma cell dyscrasias
Dicke C, Schneppenheim S, Holstein K, Spath B, Bokemeyer C, Dittmer R, Budde U, Langer F
ANN HEMATOL. 2016;95(6):945-57.

Tissue factor-dependent and -independent pathways of systemic coagulation activation in acute myeloid leukemia: a single-center cohort study
Dicke C, Amirkhosravi A, Spath B, Jiménez-Alcázar M, Fuchs T, Davila M, Francis J, Bokemeyer C, Langer F
EXP HEMATOL ONCOL. 2015;4:22.

Atypical venous thromboses in myeloproliferative neoplasias
Dicke C, Frölich A, Holstein K, Bokemeyer C, Langer F
PHLEBOLOGIE. 2015;44(6):324–329.

Pathophysiology of Trousseau's syndrome
Dicke C, Langer F
HAMOSTASEOLOGIE. 2015;35(1):52-9.

Acquired hemophilia A and von Willebrand syndrome in a patient with late-onset systemic lupus erythematosus
Dicke C, Holstein K, Schneppenheim S, Dittmer R, Schneppenheim R, Bokemeyer C, Iking-Konert C, Budde U, Langer F
EXP HEMATOL ONCOL. 2014;3:21.

Retroperitoneal fibrosis as manifestation of chronic GVHD after allogeneic hematopoietic SCT
Dicke C, Kertész A, Henke R, Hasenkamp J, Jung W, Trümper L, Wulf G
BONE MARROW TRANSPL. 2013;48(3):467-8.

Letzte Aktualisierung aus dem FIS: 28.11.2024 - 03:43 Uhr